These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 108995)

  • 1. Identification of specific antibodies to extractable nuclear antigens by passive immunodiffusion.
    Kozin F; Fowler M
    Am J Clin Pathol; 1979 Apr; 71(4):437-40. PubMed ID: 108995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
    Maddison PJ; Mogavero H; Reichlin M
    J Rheumatol; 1978; 5(4):407-11. PubMed ID: 310884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
    Sharp GC; Irvin WS; May CM; Holman HR; McDuffie FC; Hess EV; Schmid FR
    N Engl J Med; 1976 Nov; 295(21):1149-54. PubMed ID: 1086429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The measurement of antibodies to extractable nuclear antigen.
    Dorsch CA; White GM; Berzofsky RN
    Am J Clin Pathol; 1979 Mar; 71(3):333-7. PubMed ID: 107791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.
    Tan EM
    Adv Immunol; 1982; 33():167-240. PubMed ID: 6182766
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiles of antinuclear antibodies in systemic rheumatic diseases.
    Notman DD; Kurata N; Tan EM
    Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of patients with antibodies directed against proliferating cell nuclear antigen.
    Fritzler MJ; McCarty GA; Ryan JP; Kinsella TD
    Arthritis Rheum; 1983 Feb; 26(2):140-5. PubMed ID: 6600614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis.
    Kurata N; Tan EM
    Arthritis Rheum; 1976; 19(3):574-80. PubMed ID: 1084750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatology and diagnosis in connective tissue disease. Antibodies to extractable ribonucleoprotein in 123 patients reacting with cell nuclei in the immunofluorescence test.
    Jonsson J
    Scand J Rheumatol; 1976; 5(3):177-83. PubMed ID: 790556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinuclear antibodies in the investigation of rheumatic diseases.
    Fritzler MJ
    Bull Rheum Dis; 1985; 35(6):1-10. PubMed ID: 3879803
    [No Abstract]   [Full Text] [Related]  

  • 12. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G; Hiepe F
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies reacting with ribosomal ribonucleoprotein in connective tissue diseases.
    Miyachi K; Tan EM
    Arthritis Rheum; 1979 Jan; 22(1):87-93. PubMed ID: 103560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of patients with serum antibodies to extractable nuclear antigens.
    Leibfarth JH; Persellin RH
    Arthritis Rheum; 1976; 19(5):851-6. PubMed ID: 786296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between snRNA species contained in nuclear antigens recognized by autoantibodies and the clinical profile in systemic rheumatic diseases.
    Assens C; Graafland H; Liautard JP; Sri-Widada J; Brunel C; Jeanteur P
    Biomed Pharmacother; 1982; 36(3):134-9. PubMed ID: 6185159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal nuclear immunofluorescence. Is it a specific marker for mixed connective tissue disease?
    Kent LT; Hu CH; Michel B; Tan EM; Moskowitz RW
    J Dermatol; 1984 Apr; 11(2):121-8. PubMed ID: 6384307
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y; Lotan C
    Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
    [No Abstract]   [Full Text] [Related]  

  • 18. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
    Molden DP; Suzuki H; Nakamura RM
    Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANAs in systemic rheumatic disease. Diagnostic significance.
    Tan EM; Robinson CA; Nakamura RM
    Postgrad Med; 1985 Sep; 78(3):141-2, 145-8. PubMed ID: 3875842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T; Kahn MF; Peltier AP; de SEZE S
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.